Objectives: bloodstream infections (BSI) due to multidrug-resistant (MDR) Acinetobacter baumannii (AB) have been increasingly observed among hospitalized patients.Methods: prospective, observational study conducted among 12 large tertiary-care hospitals, across 7 Italian regions. From June 2017 to June 2018 all consecutive hospitalized patients with bacteremia due to MDR-AB were included and analyzed in the study.Results: During the study period 281 episodes of BSI due to MDR-AB were observed: 98 (34.8%) episodes were classified as primary bacteremias, and 183 (65.2%) as secondary bacteremias; 177 (62.9%) of them were associated with septic shock. Overall, 14-day mortality was observed in 172 (61.2%) patients, while 30-day mortality in 207 (73.6%) patients. On multivariate analysis, previous surgery, continuous renal replacement therapy, inadequate source control of infection, and pneumonia were independently associated with higher risk of septic shock. Instead, septic shock and Charlson Comorbidity Index >3 were associated with 14-day mortality, while adequate source control of infection and combination therapy with survival. Finally, septic shock, previous surgery, and aminoglycoside-containing regimen were associated with 30-day mortality, while colistin-containing regimen with survival.Conclusions: BSI caused by MDR-AB represents a difficult challenge for physicians, considering the high rates of septic shock and mortality associated with this infection. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study / Russo, A.; Bassetti, M.; Ceccarelli, G.; Carannante, N.; Losito, A. R.; Bartoletti, M.; Corcione, S.; Granata, G.; Santoro, A.; Giacobbe, D. R.; Peghin, M.; Vena, A.; Amadori, F.; Segala, F. V.; Giannella, M.; Di Caprio, G.; Menichetti, F.; Del Bono, V.; Mussini, C.; Petrosillo, N.; De Rosa, F. G.; Viale, P.; Tumbarello, M.; Tascini, C.; Viscoli, C.; Venditti, M.. - In: JOURNAL OF INFECTION. - ISSN 0163-4453. - 79:2(2019), pp. 130-138. [10.1016/j.jinf.2019.05.017]

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study

Santoro A.;Menichetti F.;Mussini C.;
2019

Abstract

Objectives: bloodstream infections (BSI) due to multidrug-resistant (MDR) Acinetobacter baumannii (AB) have been increasingly observed among hospitalized patients.Methods: prospective, observational study conducted among 12 large tertiary-care hospitals, across 7 Italian regions. From June 2017 to June 2018 all consecutive hospitalized patients with bacteremia due to MDR-AB were included and analyzed in the study.Results: During the study period 281 episodes of BSI due to MDR-AB were observed: 98 (34.8%) episodes were classified as primary bacteremias, and 183 (65.2%) as secondary bacteremias; 177 (62.9%) of them were associated with septic shock. Overall, 14-day mortality was observed in 172 (61.2%) patients, while 30-day mortality in 207 (73.6%) patients. On multivariate analysis, previous surgery, continuous renal replacement therapy, inadequate source control of infection, and pneumonia were independently associated with higher risk of septic shock. Instead, septic shock and Charlson Comorbidity Index >3 were associated with 14-day mortality, while adequate source control of infection and combination therapy with survival. Finally, septic shock, previous surgery, and aminoglycoside-containing regimen were associated with 30-day mortality, while colistin-containing regimen with survival.Conclusions: BSI caused by MDR-AB represents a difficult challenge for physicians, considering the high rates of septic shock and mortality associated with this infection. (C) 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
2019
28-mag-2019
79
2
130
138
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study / Russo, A.; Bassetti, M.; Ceccarelli, G.; Carannante, N.; Losito, A. R.; Bartoletti, M.; Corcione, S.; Granata, G.; Santoro, A.; Giacobbe, D. R.; Peghin, M.; Vena, A.; Amadori, F.; Segala, F. V.; Giannella, M.; Di Caprio, G.; Menichetti, F.; Del Bono, V.; Mussini, C.; Petrosillo, N.; De Rosa, F. G.; Viale, P.; Tumbarello, M.; Tascini, C.; Viscoli, C.; Venditti, M.. - In: JOURNAL OF INFECTION. - ISSN 0163-4453. - 79:2(2019), pp. 130-138. [10.1016/j.jinf.2019.05.017]
Russo, A.; Bassetti, M.; Ceccarelli, G.; Carannante, N.; Losito, A. R.; Bartoletti, M.; Corcione, S.; Granata, G.; Santoro, A.; Giacobbe, D. R.; Peghi...espandi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0163445319301616-main.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 857.02 kB
Formato Adobe PDF
857.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1184749
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 75
  • ???jsp.display-item.citation.isi??? 73
social impact